Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tonny Johnson

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Immunological Methods|November 13, 2025
Cell-based potency assay for anti-CD3-anti-CD19 diabodyTania L Weiss, Justine Paniagua, Tonny Johnson, et al.
Molecular Therapy. Methods & Clinical Development|August 13, 2025
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engagerMark A Currier, Allen Reha, Brian Hutzen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|November 13, 2025
Cell-based potency assay for anti-CD3-anti-CD19 diabodyTania L Weiss, Justine Paniagua, Tonny Johnson, et al.
Molecular Therapy. Methods & Clinical Development|August 13, 2025
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engagerMark A Currier, Allen Reha, Brian Hutzen, et al.
Pageof 1